A randomized controlled trial of an integrated care intervention to increase eligibility for chronic hepatitis C treatment

American Journal of Gastroenterology

Volumn 106, Issue 10, 2011, Pages 1777-1786

  Evon, Donna M ^a   Simpson, Kelly ^a   Kixmiller, Scott ^a   Galanko, Joseph ^a   Dougherty, Karen ^a   Golin, Carol ^a,b,c   Fried, Michael W ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b The University of North Carolina at Chapel Hill   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON;

ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; ANTIVIRAL THERAPY; ARTICLE; COMORBIDITY; CONTROLLED STUDY; ETHNICITY; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; INTEGRATED HEALTH CARE SYSTEM; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOOD; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBSTANCE ABUSE;

ADULT; ANTIVIRAL AGENTS; COMORBIDITY; DELIVERY OF HEALTH CARE, INTEGRATED; ELIGIBILITY DETERMINATION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; LOGISTIC MODELS; MALE; MENTAL DISORDERS; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYETHYLENE GLYCOLS; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; RECOMBINANT PROTEINS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 80053894219     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.219     Document Type: Article

References (54)

1. Evon DM, Verma A, Dougherty KA, et al. High deferral rates and poorer treatment outcomes for HCV patients with psychiatric and substance use comorbidities. Dig Dis Sci 2007; 52: 3251-8. (Pubitemid 47512531)
2. Falck-Ytter Y, Kale H, Mullen KD, et al. Surprisingly small effect of antiviral treatment in patients with hepatitis C. Ann Intern Med 2002; 136: 288-92. (Pubitemid 34150758)
3. Muir AJ, Provenzale D. A descriptive evaluation of eligibility for therapy among veterans with chronic hepatitis C virus infection. J Clin Gastroenterol 2002; 34: 268-71. (Pubitemid 34177383)
4. Bini EJ, Brau N, Currie S, et al. Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection. Am J Gastroenterol 2005; 100: 1772-9. (Pubitemid 41648433)
5. Loft is JM, Matthews AM, Hauser P. Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and management. Drugs 2006; 66: 155-74. (Pubitemid 43213901)
6. Rocca LG, Yawn BP, Wollan P, et al. Management of patients with hepatitis C in a community population: diagnosis, discussions, and decisions to treat. Ann Fam Med 2004; 2: 116-24. (Pubitemid 39329078)
7. Edlin BR, Seal KH, Lorvick J, et al. Is it justifiable to withhold treatment for hepatitis C from illicit-drug users? N Engl J Med 2001; 345: 211-5.
8. Castera L, Constant A, Henry C, et al. Impact on adherence and sustained virological response of psychiatric side effects during peginterferon and ribavirin therapy for chronic hepatitis C. Aliment Pharmacol Ther 2006; 24: 1223-30. (Pubitemid 44427510)
9. Schaefer M, Schmidt F, Folwaczny C, et al. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups. Hepatology 2003; 37: 443-51. (Pubitemid 36152544)
10. Schaefer M, Heinz A, Backmund M. Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules? Addiction 2004; 99: 1167-75. (Pubitemid 39215278)
11. Schaefer M, Hinzpeter A, Mohmand A, et al. Hepatitis C treatment in " difficult-to-treat " psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects. Hepatology 2007; 46: 991-8. (Pubitemid 350144763)
12. Ho SB, Groessl E, Dollarhide A, et al. Management of chronic hepatitis C in veterans: the potential of integrated care models. Am J Gastroenterol 2008; 103: 1810-23.
13. Litwin AH, Soloway I, Gourevitch MN. Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities. Clin Infect Dis 2005; 40 (Suppl 5): S339-45. (Pubitemid 40490222)
14. Sylvestre DL, Loftis JM, Hauser P, et al. Co-occurring hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care. J Urban Health 2004; 81: 719-34. (Pubitemid 39457952)
15. Wagner GJ, Ryan GW. Hepatitis C virus treatment decision-making in the context of HIV co-infection: the role of medical, behavioral and mental health factors in assessing treatment readiness. AIDS 2005; 19 (Suppl 3): S190-8. (Pubitemid 41682187)
16. Rifai MA, Moles JK, Short DD. Hepatitis C treatment eligibility and outcomes among patients with psychiatric illness. Psychiatr Serv 2006; 57: 570-2.
17. Edlin BR, Kresina TF, Raymond DB, et al. Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clin Infect Dis 2005; 40 (Suppl 5): S276-85. (Pubitemid 40490212)
18. McLaren M, Garber G, Cooper C. Barriers to hepatitis C virus treatment in a Canadian HIV-hepatitis C virus coinfection tertiary care clinic. Can J Gastroenterol 2008; 22: 133-7. (Pubitemid 351566106)
19. Rosenberg SD, Goodman LA, Osher FC, et al. Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health 2001; 91: 31-7. (Pubitemid 32049263)
20. Klinkenberg WD, Caslyn RJ, Morse GA, et al. Prevalence of human immunodeficiency virus, hepatitis B, and hepatitis C among homeless persons with co-occurring severe mental illness and substance use disorders. Compr Psychiatry 2003; 44: 293-302. (Pubitemid 36875463)
21. Zdilar D, Franco-Bronson K, Buchler N, et al. Hepatitis C, interferon alfa, and depression. Hepatology 2000; 31: 1207-11. (Pubitemid 30351279)
22. McCarthy JJ, Flynn N. Hepatitis C in methadone maintenance patients: prevalence and public policy implications. J Addict Dis 2001; 20: 19-31. (Pubitemid 32247019)
23. Fireman M, Indest DW, Blackwell A, et al. Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): the importance of routine mental health screening as a component of a comanagement model of care. Clin Infect Dis 2005; 40 (Suppl 5): S286-91. (Pubitemid 40490213)
24. Birkhead GS, Klein SJ, Candelas AR, et al. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach. Int J Drug Policy 2007; 18: 417-25. (Pubitemid 47376915)
25. Goldberg RW. Supported medical care: a multi-faceted approach to helping HIV/hepatitis C virus co-infected adults with serious mental illness. AIDS 2005; 19 (Suppl 3): S215-20. (Pubitemid 41682190)
26. Grebely J, Knight E, Genoway KA, et al. Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support. Eur J Gastroenterol Hepatol 2010; 22: 270-7.
27. Zaller N, Gillani FS, Rich JD. A model of integrated primary care for HIV-positive patients with underlying substance use and mental illness. AIDS Care 2007; 19: 1128-33. (Pubitemid 350223194)
28. Willenbring ML. Integrating care for patients with infectious, psychiatric, and substance use disorders: concepts and approaches. AIDS 2005; 19 (Suppl 3): S227-37. (Pubitemid 41682192)
29. Knott A, Dieperink E, Willenbring ML, et al. Integrated psychiatric/medical care in a chronic hepatitis C clinic: effect on antiviral treatment evaluation and outcomes. Am J Gastroenterol 2006; 101: 2254-62. (Pubitemid 44477552)
30. Grebely J, Genoway K, Khara M, et al. Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection. Int J Drug Policy 2007; 18: 437-43. (Pubitemid 47381422)
31. Neri S, Bertino G, Petralia A, et al. A multidisciplinary therapeutic approach for reducing the risk of psychiatric side effects in patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin. J Clin Gastroenterol 2010; 44: e210-7.
32. Seeff LB, Hoofnagle JH. National institutes of health consensus development conference: management of hepatitis C: 2002. Hepatology 2002; 36 (5, Suppl 1): S1-2. (Pubitemid 35253458)
33. McConnaughy E, Prochaska J, Velicer W. Stages of change in psychotherapy: measurement and sample profiles. Psychotherapy: Theory, Research and Practice 1983; 20: 368-75. (Pubitemid 14239267)
34. Prochaska JO, DiClemente CC. The Transtheoretical Approach: Crossing Traditional Boundaries of Therapy. Dow Jones-Erwin: Homewood, IL, 1984.
35. Miller WR. Enhancing Motivation for Change in Substance Abuse Treatment. Treatment Improvement Protocol (TIP) Series 35. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment (DHHD Publication No. (SMA) 99-3354): Rockville, MD, 1999.
36. Drake RE, O'Neal EL, Wallach MA. A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. J Subst Abuse Treat 2008; 34: 123-38. (Pubitemid 350216356)
37. Craw JA, Gardner LI, Marks G, et al. Brief strengths-based case management promotes entry into HIV medical care: results of the antiretroviral treatment access study-II. J Acquir Immune Defic Syndr 2008; 47: 597-606. (Pubitemid 351442023)
38. Husbands W, Browne G, Caswell J, et al. Case management community care for people living with HIV/AIDS (PLHAs). AIDS Care 2007; 19: 1065-72. (Pubitemid 47402899)
39. Miller WR, Rollnick S. Motivational Interviewing: Preparing People for Change, 2nd edn. Guilford Press: New York, 2002.
40. Beck A, Steer R, Brown GK. Manual for Beck Depression Inventory-II. Psychological Corporation: San Antonio, TX, 1996.
41. Spielberger C, Gorsuch R, Lushene R, et al. Manual for the State-Trait Anxiety Inventory. Mind Garden: Palo Alto, CA, 1983.
42. Saunders JB, Aasland OG, Babor TF, et al. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction 1993; 88: 791-804. (Pubitemid 23194530)
43. First M, Spitzer R, Gibbon M, et al. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP). Biometrics Research, New York State Psychiatric Institute: New York, 2002.
44. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556-62. (Pubitemid 29384163)
45. Volk ML. Antiviral therapy for hepatitis C: why are so few patients being treated? J Antimicrob Chemother 2010; 65: 1327-9.
46. Volk ML, Tocco R, Saini S, et al. Public health impact of antiviral therapy for hepatitis C in the United States. Hepatology 2009; 50: 1750-5.
47. Morrill JA, Shrestha M, Grant RW. Barriers to the treatment of hepatitis C. Patient, provider, and system factors. J Gen Intern Med 2005; 20: 754-8. (Pubitemid 41141009)
48. Evon D, Simpson K, Esserman D, et al. Barriers to accessing care in patients with chronic hepatitis C: the impact of depression. Aliment Pharmacol Therap 2010; 32: 1163-73.
49. McHutchison JG, Bacon BR, Owens GS. Making it happen: managed care considerations in vanquishing hepatitis C. Am J Manag Care 2007; 13 (Suppl 12): S327-36.
50. Soto TA, Bell J, Pillen MB. Literature on integrated HIV care: a review. AIDS Care 2004; 16 (Suppl 1): S43-55. (Pubitemid 39627974)
51. Fleming CA, Tumilty S, Murray JE, et al. Challenges in the treatment of patients coinfected with HIV and hepatitis C virus: need for team care. Clin Infect Dis 2005; 40 (Suppl 5): S349-54. (Pubitemid 40490224)
52. Nguyen HA, Miller AI, Dieperink E, et al. Spectrum of disease in U.S. veteran patients with hepatitis C. Am J Gastroenterol 2002; 97: 1813-20. (Pubitemid 34761412)
53. Rifai MA, Indest D, Loftis J, et al. Psychiatric management of the hepatitis C patient. Curr Treat Opt Gastroenterol 2006; 9: 508-19.
54. Barrera M Jr, Glasgow RE, McKay HG, et al. Do Internet-based support interventions change perceptions of social support?: an experimental trial of approaches for supporting diabetes self-management. Am J Comm Psychol 2002; 30: 637-54.